To investigate the feasibility and security of thoracoscopic anatomical pulmonary segmentectomy in the treatment of pulmonary nodule.

Department of thoracic surgery, The First Medical Center of Chinese PLA General Hospital From Mar. 2017 to Dec.2018, we performed thoracoscopic anatomical pulmonary segmentectomy for 86 patients. Three incisions were used in our procedure. The postoperative hospital stay and incidence of postoperative complication were carried out. The status, advantages and indications of thoracoscopic anatomical segmentectomy were analyzed.

All the 86 patients underwent thoracoscopic anatomical pulmonary segmentectomy successfully without conversion to thoracotomy or lobectomy. The mean operation time was(160.59±42.43)min. The mean intraoperative blood loss was (27.06±1.23)ml. The mean number of lymph node dissections was(6.78±3.54). The chest tubes were maintained in position for(4.84±2.12)d. The mean postoperative hospital stay was (6.53±1.41)d. Postoperative pathological examination showed adenocarcinoma in 78 cases, squamous cell carcinoma in 1, mucinous adenocarcinoma in 1, benign nodule in 6 and the primary non-small cell lung cancer was classified as stageⅠa. No severe postoperative complications, death and local recurrence up to now.

Thoracoscopic anatomical pulmonary segmentectomy has the advantages of minimal trauma, fast recovery and short postoperative hospital stay. Its long-term prognosis is lack of prospective data support, so the indication of thoracoscopic anatomical pulmonary segmentectomy should be strictly controlled.